Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Rev Mal Respir ; 22(4): 587-94, 2005 Sep.
Artigo em Francês | MEDLINE | ID: mdl-16294178

RESUMO

INTRODUCTION: Several epidemiological studies have indicated an increased risk of lung cancer associated with indoor radon exposure. As part of a large European project, a hospital based case-control study was carried out in four regions of France: Auvergne, Brittany, Languedoc-Roussillon and Limousin. MATERIAL AND METHODS: Individual data on demographic characteristics, residential history, smoking and occupational exposures were collected during face-to-face interviews. Radon concentrations were measured in each dwelling occupied by the subject during the 30-year period prior to the interview. RESULTS: 486 cases and 984 controls were included in the study. After adjustment for age, sex, region, smoking history and occupational exposure, the risk of lung cancer increased by 4% per 100 Bq/m(3), when considering cumulative exposure in the 30 years prior to diagnosis. CONCLUSION: The study indicates a positive association between lung cancer risk and indoor radon exposure. The risk estimate per unit of exposure is in agreement with other recently published indoor case-control studies.


Assuntos
Poluição do Ar em Ambientes Fechados , Carcinógenos Ambientais/efeitos adversos , Habitação , Neoplasias Pulmonares/induzido quimicamente , Neoplasias Pulmonares/epidemiologia , Radônio/efeitos adversos , Idoso , Estudos de Casos e Controles , Estudos Epidemiológicos , Feminino , França/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Medição de Risco , Fatores de Risco , Fumar/efeitos adversos , Inquéritos e Questionários
2.
Radiat Prot Dosimetry ; 102(3): 229-48, 2002.
Artigo em Inglês | MEDLINE | ID: mdl-12430962

RESUMO

A parameter uncertainty analysis has been performed to derive the probability distribution of the weighted equivalent dose to lung for an adult (w(lung) H(lung)) per unit exposure to radon progeny in the home. The analysis was performed using the ICRP Publication 66 human respiratory tract model (HRTM) with tissue weighting factor for the lung, w(lung) = 0.12 and the radiation weighting factor for alpha particles, wR = 20. It is assumed that the HRTM is a realistic representation of the physical and biological processes, and that the parameter values are uncertain. The parameter probability distributions used in the analysis were based on a combination of experimental results and expert judgement from several prominent European scientists. The assignment of the probability distributions describing the uncertainty in the values of the assigned fractions (ABB, Abb, AAI) of the tissue weighting factor proved difficult in practice due to lack of quantitative data. Because of this several distributions were considered. The results of the analysis give a mean value of w(lung) H(lung) per unit exposure to radon progeny in the home of 15 mSv per working level month (WLM) for a population. For a given radon gas concentration, the mean value of w(lung) H(lung) per unit exposure is 13 mSv per 200 Bq.m(-3).y of 222Rn. Parameters characterising the distributions of w(lung) H(lung) per unit exposure are given. If the ICRP weighting factors are fixed at their default values (ABB, Abb, AAI = 0.333, 0.333, 0.333; w(lung) = 0.12; and wr = 20) then on the basis of this uncertainty analysis it is extremely unlikely (P approximately 0.0007) that a value of Hw/Pp for exposure in the home is as low as 4 mSv per WLM, the value determined with the epidemiological approach. Even when the uncertainties in the ABB, Abb, AAI, values are included then this probability is predicted to be between 0.01 to 0.08 depending upon the distribution assumed for describing the uncertainties in the ABB, Abb, AAI, values. Thus, it is concluded that the uncertainties in the HRTM parameters considered in this study cannot totally account for the discrepancy between the dosimetric and epidemiological approaches.


Assuntos
Poluentes Radioativos do Ar/análise , Pulmão/efeitos da radiação , Modelos Biológicos , Radiometria/métodos , Produtos de Decaimento de Radônio/análise , Administração por Inalação , Adulto , Poluentes Radioativos do Ar/efeitos adversos , Poluição do Ar em Ambientes Fechados/análise , Partículas alfa , Monitoramento Ambiental/métodos , Humanos , Pulmão/metabolismo , Pulmão/patologia , Modelos Estatísticos , Tamanho do Órgão/efeitos da radiação , Doses de Radiação , Lesões por Radiação/etiologia , Proteção Radiológica/normas , Radiometria/normas , Produtos de Decaimento de Radônio/administração & dosagem , Produtos de Decaimento de Radônio/efeitos adversos , Sistema Respiratório/metabolismo , Sistema Respiratório/efeitos da radiação , Processos Estocásticos , Distribuição Tecidual
3.
Biochem Biophys Res Commun ; 286(3): 464-71, 2001 Aug 24.
Artigo em Inglês | MEDLINE | ID: mdl-11511081

RESUMO

This study deals with the development of gene therapy in the treatment of lung diseases. It reports on the use of ultrasonic nebulization to administer plasmid-lipid complexes to the lungs of mice to transfect their epithelial cells. A plasmid complexed to cationic lipids was aerosolized using an ultrasonic nebulizer. We then characterized the lipoplex size and visualized the lipoplex by electron microscopy. Finally, we assessed the in vivo transgene expression in the lungs further to the aerosolization of different lipid-plasmid formulations. The nebulizer-generated particles were small and looked like a string composed of little and more or less cubic units. Transgene expression was detected in the lungs of mice further to a 20-min exposure to aerosol particles produced with the ultrasonic nebulizer. The results obtained with our optimized plasmid-lipid-NaCl formulation suggest that this route can be used to administer an appropriate gene to the airways for the treatment of respiratory disorders.


Assuntos
Aerossóis/administração & dosagem , Terapia Genética , Pneumopatias/terapia , Transfecção/métodos , Administração por Inalação , Aerossóis/uso terapêutico , Animais , Betaína/administração & dosagem , Betaína/análogos & derivados , Cátions/administração & dosagem , DNA/administração & dosagem , Diglicerídeos/administração & dosagem , Feminino , Lipídeos/administração & dosagem , Pulmão/metabolismo , Camundongos , Microscopia Eletrônica de Varredura , Organofosfonatos/administração & dosagem , Plasmídeos , Compostos de Amônio Quaternário/administração & dosagem , Transgenes , Ultrassom
4.
Health Phys ; 63(2): 172-8, 1992 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1399615

RESUMO

Membranes that exclude water but are permeable to radon can extend the range of environments where many radon detection systems could operate. We have studied the permeation of 222Rn through polypropylene membranes separating air and water phases. The permeation coefficient and the activation energy were calculated for various conditions. Potential applications, such as in situ detection of radon in water, are discussed.


Assuntos
Membranas Artificiais , Polímeros , Radônio/farmacocinética , Poluentes Radioativos da Água/análise , Permeabilidade , Radônio/análise , Fatores de Tempo
5.
Pathol Biol (Paris) ; 25(8): 517-21, 1977 Oct.
Artigo em Francês | MEDLINE | ID: mdl-413086

RESUMO

219 monoclonal gammapathies have been studied since 1rst January 1973 up to 31st December 1975, regarding 121 males and 98 females, 121 myeloma (mean age: 66 years), 38 Waldenstrom's macroglobulinemia (mean age: 7u years) and 60 various monoclonal gammapathies, among which 19 benign monoclonal gammapathies (mean age: 73 years). 214 immunoelectrophoresis have been performed: 110 IgG, 46 IgA, 49 IgM, 8 light chain myelomas and 1 without M-component myeloma. Bence-Jones proteinuria was detected only in 51,1% of cases.


Assuntos
Imunoglobulinas/análise , Mieloma Múltiplo/imunologia , Paraproteinemias/imunologia , Macroglobulinemia de Waldenstrom/imunologia , Idoso , Feminino , Humanos , Cadeias Pesadas de Imunoglobulinas/análise , Cadeias Leves de Imunoglobulina/análise , Masculino , Pessoa de Meia-Idade , Paraproteinemias/classificação , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA